Serum IgA Test Price and Details at Chughtai Lab
Book at Chughtai Lab · Lahore, Pakistan
Book this test
Introduction to Serum IgA Testing
The Serum Immunoglobulin A (IgA) test is a highly specialized immunological laboratory investigation that quantifies the level of IgA antibodies in a patient’s blood. Immunoglobulins, also known as antibodies, are glycoprotein molecules produced by plasma cells, which are a key component of the adaptive immune system. Among the five primary classes of immunoglobulins (IgG, IgA, IgM, IgD, and IgE), IgA plays a critical and unique role in mucosal immunity. It serves as the first line of defense against invading pathogens at mucosal surfaces, which include the respiratory tract, gastrointestinal tract, and urogenital tract. While IgA is most abundant in external secretions such as saliva, tears, colostrum, and bronchial mucus, a measurable fraction circulates in the blood serum. Measuring this serum fraction provides invaluable clinical insights into a patient’s overall immune status, mucosal barrier integrity, and potential underlying hematological or autoimmune conditions.
At Chughtai Lab, a premier diagnostic network in Pakistan, the Serum IgA test is performed using automated, state-of-the-art clinical chemistry and immunology analyzers. These systems utilize advanced immunoturbidimetric or nephelometric assays to ensure the highest degree of analytical sensitivity and specificity. By measuring serum IgA levels, clinical pathologists and treating physicians can evaluate humoral immunity, screen for selective immunodeficiencies, investigate chronic gastrointestinal disorders, and monitor specific plasma cell dyscrasias. The diagnostic value of this test is particularly pronounced when interpreted alongside other immunoglobulins (IgG and IgM) to construct a comprehensive immunological profile of the patient.
Clinical Procedure: What to Expect
Patient Preparation
To ensure the utmost accuracy of the Serum IgA test results, patients should adhere to the following preparation guidelines:
- No Fasting Required: Fasting is generally not necessary for a standalone Serum IgA test. Patients may eat and drink normally prior to sample collection. However, if other tests are ordered concurrently that require fasting (such as fasting blood glucose or a lipid profile), those specific requirements must be followed.
- Medication Disclosure: Patients must inform their healthcare provider and the laboratory staff of all medications, supplements, and therapies they are currently undergoing. Immunosuppressive drugs, corticosteroids, chemotherapy, and certain anticonvulsants can significantly alter immunoglobulin levels and must be documented.
- Recent Blood Products: If the patient has received a blood transfusion, intravenous immunoglobulin (IVIG) therapy, or other blood products within the past few months, this must be disclosed, as it can temporarily affect serum immunoglobulin concentrations.
- Hydration: Adequate hydration is recommended prior to the blood draw, as it facilitates easier venous access and ensures a smooth venipuncture process.
During the Procedure
The collection of a blood sample for the Serum IgA test at Chughtai Lab follows standard, sterile phlebotomy protocols to ensure patient safety and sample integrity:
- Patient Positioning: The patient is comfortably seated in a phlebotomy chair. The phlebotomist will ask the patient to extend their arm and will inspect the antecubital fossa (the crease of the elbow) to identify a suitable vein.
- Sanitization: The selected site is thoroughly cleansed with an antiseptic swab (typically 70% isopropyl alcohol) and allowed to air dry to prevent contamination and minimize the risk of infection.
- Tourniquet Application: A sterile tourniquet is applied a few inches above the selected venipuncture site to restrict venous blood flow, making the veins more prominent and easier to access.
- Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically a gold-top serum separator tube or a red-top clot activator tube) is gently inserted into the vein. The patient may feel a brief, minor pinch or prick.
- Sample Collection: The required volume of blood is drawn into the tube. Once the collection is complete, the tourniquet is released, and the needle is carefully withdrawn.
- Post-Draw Care: Immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis. A small adhesive bandage is then applied. The entire procedure takes less than five minutes.
- Safety and Comfort: Chughtai Lab phlebotomists adhere to strict infection control measures, including the use of fresh gloves for every patient and the immediate disposal of needles into designated sharps containers.
When is a Serum IgA Test Performed?
Recurrent Mucosal Infections
Physicians frequently request a Serum IgA test when a patient presents with a history of recurrent, chronic, or unusually severe infections affecting mucosal surfaces. This includes recurrent otitis media (ear infections), chronic sinusitis, frequent bronchitis, and recurrent pneumonia. Because IgA is the primary defender of the respiratory tract, a deficiency in this immunoglobulin leaves the mucosal linings vulnerable to bacterial and viral colonization. Measuring serum IgA helps clinicians determine if an underlying humoral immunodeficiency is the predisposing factor for these persistent infections.
Screening and Diagnosis of Celiac Disease
The Serum IgA test is an essential component of the diagnostic workup for celiac disease, an autoimmune enteropathy triggered by gluten ingestion. The primary screening tests for celiac disease are IgA-based autoantibodies, specifically the anti-tissue transglutaminase IgA (tTG-IgA) and anti-endomysial IgA (EMA-IgA) tests. However, approximately 2% to 3% of patients with celiac disease have selective IgA deficiency. In these individuals, IgA-based celiac screening tests will yield false-negative results. Therefore, a total Serum IgA test is performed concurrently to verify that the patient produces sufficient IgA for the autoantibody tests to be diagnostic and reliable.
Evaluation of Suspected Immunodeficiency States
When a primary or secondary immunodeficiency is suspected, a quantitative immunoglobulin panel, including Serum IgA, IgG, and IgM, is indicated. Primary immunodeficiencies, such as Selective IgA Deficiency (the most common primary immunodeficiency) or Common Variable Immunodeficiency (CVID), are characterized by significantly reduced or absent levels of IgA. Patients with these conditions may experience chronic gastrointestinal symptoms, such as chronic diarrhea, malabsorption, and unexplained weight loss, due to the lack of mucosal protection in the gut. The test assists in confirming these diagnoses and guiding immunological management.
Monitoring Plasma Cell Disorders and IgA Myeloma
In hematology, the Serum IgA test is crucial for diagnosing and monitoring plasma cell dyscrasias, particularly IgA Multiple Myeloma. Multiple myeloma is a malignancy of plasma cells that leads to the overproduction of a single type of monoclonal immunoglobulin (M-protein). When the malignant clone produces IgA, patients exhibit a marked, monoclonal elevation in serum IgA levels. Quantitative measurement of Serum IgA, along with serum protein electrophoresis (SPEP) and immunofixation, helps hematologists assess tumor burden, evaluate the effectiveness of chemotherapy or stem cell transplantation, and monitor for disease recurrence.
Investigating Autoimmune and Chronic Inflammatory Diseases
Elevated levels of polyclonal Serum IgA are frequently observed in various chronic inflammatory and autoimmune disorders. Conditions such as Henoch-Schönlein Purpura (an IgA-mediated vasculitis), IgA Nephropathy (Berger’s disease, where IgA complexes deposit in the kidneys), rheumatoid arthritis, systemic lupus erythematosus (SLE), and chronic liver diseases (such as alcoholic cirrhosis) often present with increased serum IgA. Measuring IgA levels helps clinicians assess systemic inflammatory activity, differentiate between various renal and hepatic pathologies, and monitor treatment response over time.
What Does a Serum IgA Test Detect?
The Serum IgA test is highly sensitive to alterations in the humoral immune system. Depending on the clinical context, the test can detect and help evaluate a wide range of pathological states and clinical findings, including:
- Selective IgA Deficiency: Characterized by an isolated, near-complete absence of serum IgA (typically less than 7 mg/dL) with normal levels of IgG and IgM.
- Common Variable Immunodeficiency (CVID): A primary immunodeficiency presenting with significantly decreased levels of IgA alongside reduced IgG and/or IgM.
- IgA Multiple Myeloma: A monoclonal gammopathy characterized by a massive, isolated spike in IgA levels produced by malignant plasma cells.
- Monoclonal Gammopathy of Undetermined Significance (MGUS): A premalignant plasma cell disorder that may present with a stable, low-level monoclonal IgA protein.
- IgA Nephropathy (Berger’s Disease): An autoimmune kidney disease characterized by the deposition of IgA immunoglobulins in the glomerular mesangium.
- Henoch-Schönlein Purpura (HSP): A systemic vasculitis characterized by IgA-dominant immune deposits in small blood vessels, skin, joints, intestines, and glomeruli.
- Chronic Liver Disease and Cirrhosis: Often associated with a significant polyclonal increase in serum IgA due to impaired hepatic clearance of immunoglobulins.
- Chronic Gastrointestinal Infections: Persistent mucosal infections in the gut that stimulate local and systemic IgA production.
- Inflammatory Bowel Disease (IBD): Conditions like Crohn’s disease and Ulcerative Colitis can cause elevated mucosal and serum IgA levels during active flares.
- Chronic Respiratory Infections: Ongoing bacterial or viral infections of the lungs and sinuses that trigger compensatory IgA synthesis.
- Autoimmune Hepatitis: Chronic inflammation of the liver that often presents with elevated immunoglobulins, including IgA.
- Rheumatoid Arthritis: An autoimmune joint disease where elevated serum IgA can correlate with increased disease severity and systemic manifestations.
- Systemic Lupus Erythematosus (SLE): A multi-system autoimmune disease that can alter quantitative immunoglobulin profiles, including IgA.
- Severe Malnutrition: Can lead to secondary immunodeficiency, resulting in generalized depression of immunoglobulin production, including IgA.
- Protein-Losing Enteropathy: A condition where proteins, including immunoglobulins, are lost through the gastrointestinal tract, leading to low serum IgA.
- Nephrotic Syndrome: Renal disease causing the loss of low-molecular-weight proteins in urine, which can secondarily affect serum immunoglobulin concentrations.
- Estrogen-Induced Elevations: Physiological increases in immunoglobulin levels sometimes associated with high estrogen states or oral contraceptive use.
- Immunosuppressive Drug Effects: Decreased IgA levels resulting from therapies such as chemotherapy, corticosteroids, or anti-CD20 monoclonal antibodies.
- Transient Hypogammaglobulinemia of Infancy: A temporary delay in the normal development of immunoglobulin production in infants, affecting IgA levels.
- Wiskott-Aldrich Syndrome: A rare, X-linked primary immunodeficiency that can present with abnormal immunoglobulin patterns, including variable IgA levels.
- Ataxia-Telangiectasia: A complex genetic disorder frequently associated with selective IgA deficiency in a significant percentage of affected individuals.
- Chronic Lymphocytic Leukemia (CLL): A hematological malignancy that can lead to hypogammaglobulinemia and decreased serum IgA as the disease progresses.
Turnaround Time and Report Access at Chughtai Lab
Chughtai Lab is widely recognized for its commitment to providing rapid, accurate, and highly accessible diagnostic reporting. For a routine Serum IgA test, the turnaround time is typically within 24 hours from the time of sample collection. Once the sample is processed at one of Chughtai Lab’s state-of-the-art central testing facilities, the results undergo a rigorous multi-stage quality control check by certified medical technologists and are finalized by a consultant pathologist.
Patients can access their diagnostic reports conveniently through multiple digital channels. Chughtai Lab offers an online report portal on their official website, where patients can view and download their PDF reports using their patient ID and lab number. Additionally, reports are accessible via the Chughtai Lab Mobile App, which is available for download on both iOS and Android platforms. For added convenience, patients can opt to receive their reports directly on their mobile phones via WhatsApp. Physical copies of the reports can also be collected from any Chughtai Lab collection center across Pakistan, including major hubs in Lahore, Karachi, Islamabad, Rawalpindi, and Peshawar.
Serum IgA Findings Overview
The following table provides a general clinical overview of the parameters evaluated during a Serum IgA test, along with typical normal ranges and possible abnormal findings. Please note that reference ranges can vary slightly depending on the specific laboratory instrumentation and the patient’s age.
| Structure / Parameter Evaluated | Normal Findings | Possible Abnormal Findings |
|---|---|---|
| Adult Serum IgA Levels | 70 – 400 mg/dL (approximate adult range) | Elevated: IgA Myeloma, Chronic Liver Disease, Autoimmune Disorders. Decreased: Selective IgA Deficiency, CVID, Immunosuppression. |
| Pediatric Serum IgA Levels (Infants) | 1.5 – 30 mg/dL (gradually increases with age) | Elevated: Early-onset chronic infections, congenital infections. Decreased: Transient Hypogammaglobulinemia of Infancy. |
| Pediatric Serum IgA Levels (Children) | 20 – 230 mg/dL (varies by specific age bracket) | Elevated: Chronic pediatric respiratory infections, Henoch-Schönlein Purpura. Decreased: Primary immunodeficiency syndromes. |
| Monoclonal IgA (M-Spike) | Absent (Polyclonal distribution) | Present: IgA Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS). |
| Polyclonal IgA Distribution | Normal, balanced distribution | Elevated Polyclonal IgA: Chronic active hepatitis, cirrhosis, systemic lupus erythematosus, rheumatoid arthritis. |
| IgA to IgG/IgM Ratio | Balanced immunological ratio | Altered Ratio: Specific immune responses, selective immunodeficiencies, or targeted plasma cell malignancies. |
Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.
Why Choose Chughtai Lab for Serum IgA?
- Experienced Healthcare Professionals: Chughtai Lab is staffed by highly qualified, board-certified clinical pathologists, immunologists, and experienced medical technologists who ensure the highest standards of diagnostic accuracy.
- Patient-Focused Care: The organization prioritizes patient comfort, safety, and convenience at every step of the diagnostic journey, from sample collection to report delivery.
- Quality Diagnostic Services: Operating with ISO 15189 certification and adhering to international quality control standards, Chughtai Lab guarantees reliable and reproducible test results.
- Professional Reporting: Reports are detailed, clear, and structured to provide clinicians with the precise quantitative data required for accurate diagnosis and treatment planning.
- Modern Diagnostic Approach: The laboratory utilizes fully automated, advanced immunoassay and clinical chemistry platforms to minimize human error and optimize analytical precision.
- Comfortable Environment: All Chughtai Lab collection centers across Pakistan are designed to provide a clean, hygienic, and welcoming environment for patients of all ages.
- Convenient Location: With an extensive network of hundreds of collection centers nationwide, patients can easily find a Chughtai Lab facility near their home or workplace.
- Commitment to Accurate Diagnosis: Since its inception in 1983, Chughtai Lab has maintained an unwavering commitment to diagnostic excellence, making it one of the most trusted names in healthcare in Pakistan.